Skip to main content

Home/ Cancer/ Group items tagged Redman

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman ... - 0 views

clincancerres.aacrjournals.org/...1666

Phase-II phaseII Trial Tetrathiomolybdate Advanced Kidney Cancer renal kidneycancer clinicaltrial anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis copper inhibition inhibitor inhibitors reduction medicine medline oncology science study res

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic A... - 0 views

clincancerres.aacrjournals.org/...1

Brewer GJ Dick RD Grover DK LeClaire V Tseng M Wicha Pienta K Redman BG Jahan T Sondak VK Strawderman LeCarpentier G Merajver SD. Treatment of metastatic cancer with tetrathiomolybdate an anticopper antiangiogenic agent: Phase I study. Tetrath

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study -- Brewer et al. 6 (1): 1 -- Clinical Cancer Research
1 - 2 of 2
Showing 20▼ items per page